KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Work In Process (2016 - 2026)

Zimmer Biomet Holdings has reported Work In Process over the past 16 years, most recently at $182.0 million for Q1 2026.

  • For Q1 2026, Work In Process fell 15.39% year-over-year to $182.0 million; the TTM value through Mar 2026 reached $182.0 million, down 15.39%, while the annual FY2025 figure was $181.0 million, 3.37% up from the prior year.
  • Work In Process for Q1 2026 was $182.0 million at Zimmer Biomet Holdings, up from $181.0 million in the prior quarter.
  • Over five years, Work In Process peaked at $256.3 million in Q2 2023 and troughed at $175.1 million in Q4 2024.
  • A 5-year average of $214.6 million and a median of $215.1 million in 2025 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: soared 31.57% in 2022 and later fell 28.97% in 2024.
  • Year by year, Work In Process stood at $230.9 million in 2022, then increased by 6.76% to $246.5 million in 2023, then fell by 28.97% to $175.1 million in 2024, then grew by 3.37% to $181.0 million in 2025, then grew by 0.55% to $182.0 million in 2026.
  • Business Quant data shows Work In Process for ZBH at $182.0 million in Q1 2026, $181.0 million in Q4 2025, and $197.6 million in Q3 2025.